1347 related articles for article (PubMed ID: 30668210)
1. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
2. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
3. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
4. Leukemias, myeloma, and other lymphoreticular neoplasms.
Hernández JA; Land KJ; McKenna RW
Cancer; 1995 Jan; 75(1 Suppl):381-94. PubMed ID: 8001009
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.
Dores GM; Landgren O; McGlynn KA; Curtis RE; Linet MS; Devesa SS
Br J Haematol; 2009 Jan; 144(1):86-94. PubMed ID: 19016727
[TBL] [Abstract][Full Text] [Related]
9. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
10. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
11. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003-2016.
Ellington TD; Henley SJ; Wilson RJ; Wu M; Richardson LC
Cancer Med; 2021 Jan; 10(1):386-395. PubMed ID: 33270992
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.
Skarsgard DP; Groome PA; Mackillop WJ; Zhou S; Rothwell D; Dixon PF; O'Sullivan B; Hall SF; Holowaty EJ
Cancer; 2000 Apr; 88(7):1728-38. PubMed ID: 10738233
[TBL] [Abstract][Full Text] [Related]
14. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Plasma Cell Neoplasms: A Population-Based Study.
Loap P; Vignon M; Bouscary D; Kirova Y
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):841-846. PubMed ID: 35941071
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
17. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
Rosenberg AS; Ruthazer R; Paulus JK; Kent DM; Evens AM; Klein AK
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):684-692.e3. PubMed ID: 27771291
[TBL] [Abstract][Full Text] [Related]
18. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
19. Trends in breast cancer by race and ethnicity: update 2006.
Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
[TBL] [Abstract][Full Text] [Related]
20. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
